Quantcast
Channel: Ebola News From Medical News Today
Viewing all articles
Browse latest Browse all 179

Phase 2 study of the Ebola prime-boost vaccine regimen combining MVA-BN Filo and Advac technology initiated

$
0
0
Bavarian Nordic A/S has announced that the Oxford Vaccines Group has initiated a Phase 2 clinical study of the Ebola prime-boost vaccine regimen that combines Bavarian Nordic's MVA-BN® Filo...

Viewing all articles
Browse latest Browse all 179

Latest Images

Trending Articles



Latest Images

<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>